Epidemiological analysis of COVID-19. Bolivarian Republic of Venezuela
Keywords:
comorbidity; COVID-19; asymptomatic, epidemiology; mortalityAbstract
The behavior of COVID-19 in the Bolivarian Republic of Venezuela during the period February-June 2020, is described through the epidemiological characterization according to time, space, person and type of transmission of the confirmed and deceased cases of this disease. Conditions related to mortality are identified. A descriptive, observational, retrospective study used the COVID-19 database of the Unified Health Information System (SUIS) of the Ministry of Popular Power for Health (MPPS). It is evident that after the confirmation of the first cases, the incidence remained stable until mid-May, when the curve of confirmed cases presented an abrupt inflection, which was largely related to imported cases. The disease has affected mostly male people, under 40, with a high percentage of clinically asymptomatic. The case fatality rate recorded in the period is less than 1% and is related to old age, the presence of comorbidities such as high blood pressure and / or diabetes. It is concluded that COVID-19 has mainly affected people under 40, with cases mostly related to the return of compatriots from neighboring countries, with a significant proportion of asymptomatic cases, which in turn are associated with the low rate of complications and mortality from this disease in Venezuela.
Downloads
References
De Lusignan, S., Dorward, J., Correa, A., Jones, N., Akinyemi, O., Amirthalingam, G., Andrews, N., Byford, R., Dabrera, G., Elliot, A., Ellis, J., Ferreira, F., López Bernal, J., Okusi, C., Ramsay, M., Sherlock, J., Smith, G., Williams, J., Howsam, G., Zambon, M., Hobbs, F. (2020). Risk factors for SARS-CoV-2 among patients in the Oxford Royal College of General Practitioners Research and Surveillance Centre primary care network: a cross-sectional study. The Lancet. Infectious diseases, S1473-3099(20)30371-6. Advance online publication. Recuperado en: https://doi.org/10.1016/S1473-3099(20)30371-6
Flint, S. W., & Tahrani, A. A. (2020). COVID-19 and obesity-lack of clarity, guidance, and implications for care. The lancet. Diabetes & endocrinology, 8(6), 474–475. Recuperado en : https://doi.org/10.1016/S2213-8587(20)30156-X
Menni, C., Valdes, A. M., Freidin, M. B., Sudre, C. H., Nguyen, L. H., Drew, D. A., Ganesh, S., Varsavsky, T., Cardoso, M. J., El-Sayed Moustafa, J. S., Visconti, A., Hysi, P., Bowyer, R., Mangino, M., Falchi, M., Wolf, J., Ourselin, S., Chan, A. T., Steves, C. J., & Spector, T. D. (2020). Real-time tracking of self-reported symptoms to predict potential COVID-19. Nature medicine, 10.1038/s41591-020-0916-2. Advance online publication. Recuperado en: https://doi.org/10.1038/s41591-020-0916-2
Nishiura, H., Kobayashi, T., Miyama, T., Suzuki, A., Jung, S. M., Hayashi, K., Kinoshita, R., Yang, Y., Yuan, B., Akhmetzhanov, A. R., & Linton, N. M. (2020). Estimation of the asymptomatic ratio of novel coronavirus infections (COVID-19). International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 94, 154–155. Recuperado en: https://doi.org/10.1016/j.ijid.2020.03.020
Organización Mundial de la Salud (OMS). (2020).Coronavirus disease 2019. Situation Report –51. Recuperado en: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200311-sitrep-51-covid-19.pdf?sfvrsn=1ba62e57_10
Rodacki, M. (2020). Severity of COVID-19 and diabetes mellitus: there is still a lot to be learned. Archives of Endocrinology and Metabolism, 64(3), 195-196. Epub June 12, 2020. Recuperado en: https://doi.org/10.20945/2359-3997000000261
Yanping, Z. (2020). The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) — China, 2020. China CDC Weekly, 2. DOI: Recuperado en: http://weekly.chinacdc.cn/en/article/id/e53946e2-c6c4-41e9-9a9b-fea8db1a8f51
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.